Medical AI Startup OpenEvidence Secures $200M Funding at $6B Valuation
OpenEvidence, an AI platform compared to a medical version of ChatGPT, has reportedly secured $200 million in new funding. The company’s valuation has reached $6 billion as it expands its user base among doctors and medical practitioners.
Medical AI Platform Gains Momentum
OpenEvidence, an artificial intelligence company developing specialized tools for healthcare professionals, has reportedly raised $200 million in its latest funding round, according to sources familiar with the matter. The funding values the startup company at approximately $6 billion, demonstrating continued investor confidence in specialized AI applications despite broader market concerns about artificial intelligence sector overheating.
